We are developing off-the-shelf cell therapies for corneal blindness using human induced pluripotent stem cells. Our firsts product aims to cure a rare form of blindness called limbal stem cell deficiency that currently can’t be cured. In the future, we aim to tackle the global corneal tissue shortage with stem cell based solutions.